hiv prevention study halted due to lack of benefit
a trial designed to test whether a drug made by gilead sciences inc could prevent hiv infection in women at high risk of exposure to the virus was halted early after investigators determined it would probably not be effective.
http://feeds.reuters.com/~r/reuters/healthnews/~3/qgwj4fvbkqe/us-gilead-idustre73h62620110418
8366
18 Apr 2011 21:24:26
reuters
health